Crinetics Pharmaceuticals, Inc.
CRNX
$34.47
-$0.57-1.63%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | 7.53% | 6.10% | |||
Gross Profit | -7.53% | -6.83% | |||
SG&A Expenses | 8.83% | 4.24% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 7.91% | 5.55% | |||
Operating Income | -7.91% | -6.06% | |||
Income Before Tax | -4.90% | -3.74% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -4.90% | -3.74% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -4.90% | -3.74% | |||
EBIT | -7.91% | -6.06% | |||
EBITDA | -7.96% | -6.09% | |||
EPS Basic | 8.17% | -2.35% | |||
Normalized Basic EPS | 8.17% | -2.34% | |||
EPS Diluted | 8.17% | -2.35% | |||
Normalized Diluted EPS | 8.17% | -2.34% | |||
Average Basic Shares Outstanding | 14.24% | 1.37% | |||
Average Diluted Shares Outstanding | 14.24% | 1.37% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |